ArticleTransplantation1999

Marked mitigation of transplant vascular sclerosis in FasLgld (CD95L) mutant recipients. The role of alloantibodies in the development of chronic rejection.

V Subbotin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.